(LOS ANGELES) – July 1, 2022 - In their recent publication in Cell Reports, a team of scientists, led by Xiling Shen, Ph.D., Chief Scientific Officer at the Terasaki Institute for Biomedical ...
In their recent publication in Cell Reports, a team of scientists, led by Xiling Shen, Ph.D., Chief Scientific Officer at the Terasaki Institute for Biomedical Innovation (TIBI), has demonstrated the ...
Ovarian cancer often goes undetected for a long time. In seven out of 10 patients, the tumor has already formed secondary tumors in the abdominal cavity at the time of diagnosis. These metastases are ...
UB has received a $2.3 million grant from the National Cancer Institute to identify metabolic vulnerabilities of ovarian cancer and to develop potential treatments for the disease. The research, led ...
Scientists have discovered why ovarian cancer spreads so rapidly through the abdomen. Cancer cells enlist normally protective abdominal cells, forming mixed groups that work together to invade new ...
High-grade serous ovarian cancer is the most common and aggressive form of ovarian cancer and often becomes resistant to ...
Impact of pleural effusion in ovarian cancer: A retrospective study in Lleida, Spain.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results